跳至主要内容
临床试验/JPRN-UMIN000048318
JPRN-UMIN000048318尚未招募未知

Persistence of oral 5-ASA treatment in ulcerative colitis. - Persistence of oral 5-ASA treatment in ulcerative colitis.

MOCHIDA PHARMACEUTICAL CO., LTD.0 个研究点目标入组 4,400 人开始时间: 2022年7月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
4,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. The following diagnostic or implementation records for 6 months from the previous month of the Index and for the next 13 months including the Index. - Crohn's disease - Colorectal cancer - Total and subtotal resection of the colorectal and colon 2. Oral 5-ASA prescriptions outside the approved dose range for the next 13 months, including Index date. 3. Records of unknown prescription dates for oral 5-ASA and topical preparations in the next 13 months, including the Index date. 4. Prescription with unknown drug name or standards for oral 5-ASA or topical preparations in the next 13 months, including the Index date.

研究者

相似试验